Table 1.
Basic Demographics of HCC patients in SEER-Medicare linked database 1991–2010
| TACE + | TACE − | Significance | |
|---|---|---|---|
| Population | 6432 (17.00%) | 31400 (83.00%) | |
| Age | 70.3 (9.4) | 72.4 (11.2) | <.0001 |
| Gender | 0.0044 | ||
| Male | 4482 (69.68%) | 21310 (67.87%) | |
| Female | 1950 (30.32%) | 10090 (32.13%) | |
| Ethnicity | <.0001 | ||
| White | 3982 (61.91%) | 21006 (66.90%) | |
| Black | 588 (9.14%) | 3133 (9.98%) | |
| Hispanic | 330 (5.13%) | 1489 (4.74%) | |
| Asian | 1001 (15.56%) | 2985 (9.51%) | |
| Other | 531 (8.26%) | 2787 (8.88%) | |
| HCC Risk Factors35 | |||
| HCV | 3443 (53.53%) | 7876 (25.08%) | <.0001 |
| HBV | 1281 (19.92%) | 2237 (7.12%) | <.0001 |
| Alcohol | 2200 (34.20%) | 6083 (19.37%) | <.0001 |
| Diabetes/ Obesity | 4246 (66.01%) | 14724 (46.89%) | <.0001 |
| Rare Diseases | 401 (6.23%) | 907 (2.89%) | <.0001 |
| Cirrhosis Present | 4776 (74.25%) | 12868 (40.98%) | <.0001 |
| Charlson Score | <.0001 | ||
| 0 | 1835 (28.53%) | 14808 (47.16%) | |
| 1 | 446 (6.93%) | 1691 (5.39%) | |
| 2 | 752 (11.69%) | 2599 (8.28%) | |
| ≥3 | 3399 (52.85%) | 12302 (39.18%) | |
| SES Quartile | <.0001 | ||
| 1 | 1390 (22.82%) | 7583 (25.49%) | |
| 2 | 1495 (24.54%) | 7442 (25.02%) | |
| 3 | 1509 (24.77%) | 7435 (25.00%) | |
| 4 | 1698 (27.87%) | 7285 (24.49%) |
HCC Hepatocellular Carcinoma; SEER Surveillance, Epidemiology and End Results; TACE Transarterial Chemoembolization; HCV Hepatitis C Virus; HBV Hepatitis B Virus; SES Socioeconomic Status